Company Filing History:
2 out of 378 
1 out of 12,160 
Years Active: 2018-2021
Title: Carlo Stresemann: Innovator in Pharmaceutical Chemistry
Introduction
Carlo Stresemann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various diseases, including cancer. With a total of two patents to his name, Stresemann's work reflects a commitment to advancing medical science.
Latest Patents
Stresemann's latest patents include innovative compounds such as 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides. This invention covers a range of compounds that are useful in the treatment or prophylaxis of diseases, particularly cancer. The patent details methods of preparing these compounds, as well as their pharmaceutical compositions and combinations for effective treatment. Another significant patent involves aryl-cyanoguanidine compounds, which serve as inhibitors for protein-lysine N-methyltransferase SMYD2. These compounds are designed for therapeutic use in hyper-proliferative disorders, including various forms of cancer and other serious health conditions.
Career Highlights
Throughout his career, Carlo Stresemann has worked with prominent companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that have the potential to impact the pharmaceutical industry significantly.
Collaborations
Stresemann has collaborated with notable colleagues, including Jörg Weiske and Clara Christ. These partnerships have fostered an environment of innovation and creativity, leading to the development of new therapeutic solutions.
Conclusion
Carlo Stresemann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in the fight against cancer and other serious diseases.